Intranasal Ketamine in Treatment-Resistant Depression
Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
The objective of the current study is to investigate the safety and efficacy of a single dose
of intranasal (IN) ketamine in treatment-resistant depression (TRD).